System and method for heightening an immune response

• US 20080059137A1
• Filed: 08/30/2007
• Published: 03/06/2008
• Est. Priority Date: 08/25/2004
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Jung, Edward, Wilson, Richa, Myhrvold, Nathan, Wood, Lowell, Ishikawa, Muriel
• Application Number:
  US11/897,574
• Publication Number:
  US 20080059137A1
• Time in Patent Office: Days
• US Class Current: 703/11
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: G16B 30/00 ICT specially adapted for sequence analysis involving nucleotides or amino acids
• CPC Class Codes: G16B 30/10 Sequence alignment; Homology search
• CPC Class Codes: G16C 20/50 Molecular design, e.g. of drugs

Abstract

The present application relates, in general, to a system and/or method for detection and/or treatment.

Claims

1. A method, comprising:

providing one or more antigenic attributes of one or more agents associated with at least a part of an immune response in a host; and

forming a set of the one or more antigenic attributes operable for modulating the at least a part of the immune response in the host.

2. The method of claim 1, wherein the forming a set of the one or more antigenic attributes further comprises:

forming a set including the one or more antigenic attributes displayed by the one or more agents.

3. The method of claim 1, wherein the forming a set of the one or more antigenic attributes further comprises:

forming a set including the one or more antigenic attributes present in a copy number of at least two and displayed by the one or more agents.

4. The method of claim 1, wherein the forming a set of the one or more antigenic attributes further comprises:

forming a set including the one or more antigenic attributes present in at least two of the one or more agents.

7. The method of claim 1, further comprising:

displaying one or more sequences corresponding to the one or more antigenic attributes of the one or more agents.

8. The method of claim 1, further comprising:

projecting one or more alternate courses of the at least a part of the immune response in the host associated with the one or more antigenic attributes of the one or more agents.

9. The method of claim 1, wherein the providing one or more antigenic attributes of one or more agents associated with at least a part of an immune response in a host further comprises:

projecting at least one pattern of change in the one or more antigenic attributes of the one or more agents associated with the at least a part of the immune response in the host.

10. The method of claim 9, wherein the projecting at least one pattern of change in the one or more antigenic attributes of the one or more agents associated with the at least a part of the immune response in the host further comprises:

projecting at least one pattern of change in the one or more antigenic attributes of the one or more agents in response to a treatment.

11. The method of claim 1, wherein the forming a set of the one or more antigenic attributes operable for modulating the at least a part of the immune response in the host further comprising:

forming a set of the one or more antigenic attributes of the one or more agents amenable to a treatment.

12. The method of claim 11, wherein the treatment includes:

a treatment of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

13. The method of claim 11, wherein the treatment includes:

a treatment of at least a part of at least one of a macrophage, a lymphocyte, an immune response modulator, an antigen receptor, an antigen presenting cell.

14. The method of claim 11, wherein the treatment includes:

a treatment of at least one modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

15. The method of claim 11, wherein the treatment includes:

a treatment of at least one modulator of at least a part of at least one of a macrophage, a lymphocyte, an immune response modulator, an antigen receptor, or an antigen presenting cell.

5. (canceled)

6. (canceled)

16. (canceled)

17. (canceled)

18-36. -36. (canceled)